Biotech - Press Releases

Date	Title	Company
05-Jan-2024	HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases	Human Immunology Biosciences
05-Jan-2024	LAUSANNE, Switzerland, Jan. 04, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it received a notice from the New York Stock Exchange (NYSE) on January 2, 2024 that the Company has regained compliance with the continued listing minimum price criteria set forth in Section 802.01C of the NYSE Listed Company Manual and, as a result, will be removed from the NYSE’s noncompliant issuers list. The Company previously received a notice from the NYSE that it was not in comp	ADC Therapeutics
05-Jan-2024	AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- XBiotech Inc. today announced that it plans to expand it’s campus headquarters with the construction of a new, state-of-the-art research and development facility. XBiotech has received City of Austin approval to begin excavation for site preparation and groundwork is expected to begin 1st quarter 2024. The new four-story building, to be located close to the existing 46,000 ft2 manufacturing and R&D facility, will provide key infrastructure to supp	XBiotech
05-Jan-2024	selectION, Inc. to Present Update on Clinical Progress at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024	selectION, Inc.
04-Jan-2024	Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis	Vicore Pharma Holding AB (publ)
04-Jan-2024	Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2	Biocomposites
04-Jan-2024	Boehringer Ingelheim licenses multiple Dark Antigens® from Enara Bio to develop off-the-shelf immunotherapies for non-small cell lung cancer (NSCLC)	Boehringer Ingelheim
04-Jan-2024	Aptar Digital Health and Gerresheimer Collaborate to Develop Integrated Solution for Subcutaneous Cancer Therapy	Aptar Digital Health
03-Jan-2024	AMLo Biosciences publish pivotal data for diagnostic biomarker technology AMBLor® in identifying melanomas at low risk of metastasis	AMLo Biosciences
03-Jan-2024	iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference	iTeos Therapeutics, Inc.
03-Jan-2024	PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference	PureTech Health plc
03-Jan-2024	Calibre Scientific Acquires LineaLAB	Calibre Scientific
29-Dec-2023	CD Genomics Introduces Advanced OxBS-seq Technology for Accurate Methylation Analysis	CD Genomics
29-Dec-2023	CD Genomics Unleashes the Power of Metagenomic Shotgun Sequencing	CD Genomics
29-Dec-2023	CD Genomics Unveils Groundbreaking Total RNA Sequencing and Dual RNA-seq Services	CD Genomics
28-Dec-2023	Creative Proteomics Launches Innovative Ubiquitinated Proteomics Service for Advanced Research	Creative Proteomics
28-Dec-2023	Creative Proteomics Launches Label-free Quantification Service for Advanced Protein Analysis	Creative Proteomics
28-Dec-2023	Empower Your Research with Creative Proteomics' Innovative Pull-Down Assay Service	Creative Proteomics
26-Dec-2023	Creative Enzymes Unleashes Revolutionary Trypsin-Chymotrypsin, Elevating Protease Research to New Heights	Creative Enzymes
26-Dec-2023	Creative Enzymes Releases Microorganism-Derived Bilirubin Oxidase	Creative Enzymes